# Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

> **NCT00020124** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)**

## Conditions studied

- Lung Cancer
- Malignant Mesothelioma
- Metastatic Cancer

## Interventions

- **DRUG:** doxorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00020124
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** — (—)
- **Last updated:** 2012-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020124, "Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00020124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*